Rigel to Present at the Jefferies Global Healthcare Conference in London

Rigel Pharmaceuticals (Nasdaq: RIGL) will present a company overview at the Jefferies Global Healthcare Conference in London on Tuesday, November 18, 2025 at 10:00 a.m. GMT (5:00 a.m. ET).

Rhea-AI Summary

Rigel Pharmaceuticals (Nasdaq: RIGL) will present a company overview at the Jefferies Global Healthcare Conference in London on Tuesday, November 18, 2025 at 10:00 a.m. GMT (5:00 a.m. ET).

The presentation will be delivered by Raul Rodriguez, president and CEO, and will be available via live webcast and as an archived recording on the company's Investor Relations website at www.rigel.com. Attendees are advised to connect to the website before the webcast to allow any necessary software downloads.

Argus Nov 12 session

+5.24% close to close Open Argus

Details

News Market Reaction – RIGL

On Nov 12, the day this news came out, RIGL closed 5.24% above the previous close.

Data tracked by StockTitan Argus for the Nov 12 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SOUTH SAN FRANCISCO, Calif., Nov. 12, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that Raul Rodriguez, the company's president and CEO, will present a company overview at the Jefferies Global Healthcare Conference in London on Tuesday, November 18, 2025 at 10:00 a.m. GMT (5:00 a.m. ET).

To access the live webcast or archived recording, visit the Investor Relations section of the company's website at www.rigel.com. Please connect to Rigel's website prior to the start of the live webcast to allow for any software downloads.

About Rigel
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www.rigel.com.

Contact for Investors & Media:
Investors: 
Rigel Pharmaceuticals, Inc. 
650.624.1232 
ir@rigel.com

Media:
David Rosen 
Argot Partners 
646.461.6387
david.rosen@argotpartners.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/rigel-to-present-at-the-jefferies-global-healthcare-conference-in-london-302612245.html

SOURCE Rigel Pharmaceuticals, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Rigel (RIGL) present at the Jefferies Global Healthcare Conference?

Rigel will present on November 18, 2025 at 10:00 a.m. GMT (5:00 a.m. ET).

Who will present Rigel's company overview at the Jefferies conference for RIGL?

Raul Rodriguez, Rigel's president and CEO, will deliver the company overview.

How can investors watch Rigel's (RIGL) Jefferies conference presentation?

Watch via the live webcast or archived recording on Rigel's Investor Relations website at www.rigel.com.

Will a replay of Rigel's (RIGL) Jefferies presentation be available after November 18, 2025?

Yes. An archived recording will be available on the company's Investor Relations website after the live webcast.

What time should I connect to Rigel's webcast for the Jefferies conference?

Connect before 10:00 a.m. GMT (5:00 a.m. ET) on November 18, 2025 to allow time for any software downloads.

Where can I find more information about Rigel's products and pipeline mentioned in the RIGL presentation?

Company information, marketed products, and pipeline details are available at www.rigel.com.